研究单位：[1] Department of Interventional Neuroradiology, Beijing Neurosurgical Institute[2]Xuanwu Hospital, Beijing[3]Beijing Neurosurgical Institute[4]Henan Provincial People's Hospital[5]Xinhua Hospital, Shanghai Jiao Tong University School of Medicine[6]Group of Brain Doctors[7]Peking University International Hospital[8]The First Affiliated Hospital of Zhengzhou University[9]First Affiliated Hospital of Xinjiang Medical University[10]Qilu Hospital of Shandong University[11]Nanfang Hospital of Southern Medical University[12]The First Affiliated Hospital of Nanchang University[13]RenJi Hospital[14]Second Affiliated Hospital of Nanchang University
Pipeline TM embolization device launched to China in 2014, and has been widely used to treat large width IA. Therefore, it is necessary to collect and analysis the clinical data to evaluate effectiveness and safety of its usage in Chinese population, and this may guide the clinical practice and meet the clinical needs better.
